Eli Lilly and Co

1LLY

Company Profile

  • Business description

    Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

  • Contact

    Lilly Corporate Center
    IndianapolisIN46285
    USA

    T: +1 317 276-2000

    E: [email protected]

    https://www.lilly.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    47,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,723.5017.90-0.20%
CAC 407,589.6636.210.48%
DAX 4023,350.55293.171.27%
Dow JONES (US)42,206.8235.160.08%
FTSE 1008,774.6517.15-0.20%
HKSE23,530.48292.741.26%
NASDAQ19,447.4198.86-0.51%
Nikkei 22538,403.2385.11-0.22%
NZX 50 Index12,569.0558.27-0.46%
S&P 5005,967.8413.03-0.22%
S&P/ASX 2008,505.5018.20-0.21%
SSE Composite Index3,359.902.21-0.07%

Market Movers